Bio-Rad Laboratories Inc. Cl A | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,133
2,175
2,019
2,068
2,160
2,289
Cost of Goods Sold (COGS) incl. D&A
954
991
867
895
951
1,055
Gross Income
1,178
1,184
1,152
1,174
1,209
1,234
SG&A Expense
1,015
1,029
961
1,012
1,050
1,040
Unusual Expense
10
5
5
75
19
307
Non Operating Income/Expense
9
9
9
4
9
8
Interest Expense
46
22
22
22
22
24
Pretax Income
112
132
146
42
98
513
Income Tax
35
43
33
16
24
147
Consolidated Net Income
78
89
113
26
122
366
Net Income
78
89
113
26
122
366
Net Income After Extraordinaries
78
89
113
26
122
366
Net Income Available to Common
78
89
113
26
122
366
EPS (Basic)
2.69
3.05
3.85
0.88
4.07
12.10
Basic Shares Outstanding
29
29
29
29
30
30
EPS (Diluted)
2.69
3.05
3.85
0.88
4.07
12.10
Diluted Shares Outstanding
29
29
29
30
30
30
EBITDA
311
305
293
271
278
333
Other Operating Expense
-
-
31
33
30
-
Non-Operating Interest Income
13
14
10
15
19
27
Minority Interest Expense
-
-
-
-
-
-
About Bio-Rad Laboratories
View Profile
